revumenib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
revumenib
Jun 29, 2024, 16:57 |
Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Apr 17, 2024, 18:53 |
Insight
Andrius Žučenka: As a bone marrow transplanter I trully find BMT as one the most difficult and somewhat miraculous procedures
Andrius Žučenka, Hematologist, Researcher, Lecturer and PhD Candidate at Vilnius University Hospital Santaros Klinikos, shared on…
Mar 12, 2024, 15:53 |
Blog
Naveen Pemmaraju: Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa Junior Clinical Investigator Award
Naveen Pemmaraju posted on X/Twitter: ''Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa…
Oct 27, 2023, 17:01 |
Drugs
Revumenib in relapsed or refractory KMT2Ar acute leukemia - Syndax Pharmaceuticals
Nicole McNeer, Senior Medical Director and Clinical Leader at Syndax Pharmaceuticals, shared a post by…
All:
4
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube